Hauptseite > Publikationsdatenbank > “One week on–one week off”: efficacy and side effects of dose-intensified temozolomide chemotherapy: experiences of a single center > print

001     136497
005     20210129211839.0
024 7 _ |a 10.1007/s11060-013-1048-z
|2 doi
024 7 _ |a 0167-594x
|2 ISSN
024 7 _ |a 0167-594X
|2 ISSN
024 7 _ |a 1573-7373
|2 ISSN
024 7 _ |a WOS:000316755000008
|2 WOS
024 7 _ |a altmetric:1172120
|2 altmetric
024 7 _ |a pmid:23299464
|2 pmid
037 _ _ |a FZJ-2013-03293
082 _ _ |a 610
100 1 _ |a Galldiks, Norbert
|0 P:(DE-Juel1)143792
|b 0
|u fzj
|e Corresponding author
245 _ _ |a “One week on–one week off”: efficacy and side effects of dose-intensified temozolomide chemotherapy: experiences of a single center
260 _ _ |a Dordrecht [u.a.]
|c 2013
|b Springer Science + Business Media B.V
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1374571621_14486
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
500 _ _ |3 POF3_Assignment on 2016-02-29
536 _ _ |a 333 - Pathophysiological Mechanisms of Neurological and Psychiatric Diseases (POF2-333)
|0 G:(DE-HGF)POF2-333
|c POF2-333
|x 0
|f POF II
588 _ _ |a Dataset connected to CrossRef, juser.fz-juelich.de
700 1 _ |a Berhorn, Theresa
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Blau, Tobias
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Dunkl, Veronika
|0 P:(DE-Juel1)156211
|b 3
|u fzj
700 1 _ |a Fink, Gereon R.
|0 P:(DE-Juel1)131720
|b 4
|u fzj
700 1 _ |a Schroeter, Michael
|0 P:(DE-HGF)0
|b 5
773 _ _ |a 10.1007/s11060-013-1048-z
|g Vol. 112, no. 2, p. 209 - 215
|p 209 - 215
|n 2
|0 PERI:(DE-600)2007293-4
|t Journal of neuro-oncology
|v 112
|y 2013
|x 1573-7373
856 4 _ |u https://juser.fz-juelich.de/record/136497/files/FZJ-2013-03293.pdf
|z Published final document.
|y Restricted
909 C O |o oai:juser.fz-juelich.de:136497
|p VDB
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)143792
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 3
|6 P:(DE-Juel1)156211
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)131720
913 2 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-579H
|2 G:(DE-HGF)POF3-500
|v Addenda
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Funktion und Dysfunktion des Nervensystems
|1 G:(DE-HGF)POF2-330
|0 G:(DE-HGF)POF2-333
|2 G:(DE-HGF)POF2-300
|v Pathophysiological Mechanisms of Neurological and Psychiatric Diseases
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF2
914 1 _ |y 2013
915 _ _ |a JCR/ISI refereed
|0 StatID:(DE-HGF)0010
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-3-20090406

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21